RWD150 Tirzepatide and Weight Reduction Among Individuals without Evidence of Type 2 Diabetes: Descriptive Results from Optum’s De-Identified Market Clarity Data
Abstract
Authors
T Hunter ER Hankosky AC Meeks J Ward C Chinthammit